Bottom line
GDOC vs ETHSX: the short answer
GDOC (Goldman Sachs Future Health Care Equity ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 51% by weight.
GDOC is cheaper at 0.75% vs 1.18% — a difference of $43 a year per $10,000 invested.
Over one year, GDOC returned −1.6% vs −1.9% for ETHSX.
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
GDOC vs ETHSX side by side
| GDOC | ETHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Goldman Sachs | Morgan Stanley |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.75% | 1.18% |
| Annual cost per $10k | $75 | $118 |
| 10-yr cost on $10k (prospectus) | $930 | $1,911 |
| Max front load | None | 5.25% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | −1.6% | −1.9% |
| 5-yr return (annualized) | — | +5.3% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | +10.7% | +14.2% |
| Worst quarter | −13.5% | −12.1% |
| Net assets (fund) | $20.1M | $757.9M |
| Number of holdings | 42 | 42 |
| Portfolio turnover | 46% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GDOC | ETHSX | Difference |
|---|---|---|---|
| 2024 | −1.6% | +3.5% | −5.1% |
| 2023 | +4.9% | +5.7% | −0.8% |
| 2022 | −16.9% | −9.4% | −7.5% |
Source: Fund prospectus bar charts
Holdings overlap
12 of GDOC's top 25 holdings also appear in ETHSX's top 25.
| Holding | GDOC | ETHSX |
|---|---|---|
| Eli Lilly & Company | 13.28% | 12.47% |
| Johnson & Johnson | 8.07% | 6.45% |
| Merck & Company Inc | 5.94% | 5.08% |
| Astrazeneca Plc | 4.84% | 6.24% |
| Thermo Fisher Scientific Inc | 4.52% | 2.79% |
| Argenx Se | 4.07% | 1.61% |
| Intuitive Surgical Inc | 3.90% | 2.72% |
| Boston Scientific Corp | 3.78% | 2.18% |
| Lonza Group Ag | 2.80% | 1.77% |
| Royalty Pharma Plc | 1.77% | 1.58% |
| Mettler-toledo International Inc | 1.59% | 1.36% |
| Vertex Pharmaceuticals Inc | 1.48% | 3.38% |
Source: SEC Form N-PORT
GDOC top 10
- Eli Lilly & Company — 13.28%
- Johnson & Johnson — 8.07%
- Merck & Company Inc — 5.94%
- Guardant Health Inc — 5.34%
- Astrazeneca Plc — 4.84%
- Thermo Fisher Scientific Inc — 4.52%
- Argenx Se — 4.07%
- Intuitive Surgical Inc — 3.90%
- Boston Scientific Corp — 3.78%
- Hoya Corp — 3.53%
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
FAQ
What is the difference between GDOC and ETHSX?
Which is cheaper, GDOC or ETHSX?
Should I own both GDOC and ETHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.